AI Terminal
Oxurion NV
Major Shareholding Notification • Sep 8, 2025
3987_mrq_2025-09-08_46edc387-6957-4938-bb56-e9142098b727.pdf
Major Shareholding Notification
Open in ViewerOpens in native device viewer
PRESS RELEASE
Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
Leuven, BELGIUM – September 8, 2025 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received transparency notification as follows:
Oxurion received a transparency notification on September 3, 2025, from Atlas Special Opportunities II, LLC indicating that as of August 28, 2025, it held 4,003,999 shares of the then outstanding 50,377,523 shares, and therefore crossed under the threshold (10%) by virtue of the selling of voting securities.
About Oxurion
Oxurion NV (Euronext Brussels: OXUR) is a company specializing in acquiring majority stakes in promising European pharmaceutical subcontractors. Oxurion's ambition is to build an integrated group of subcontractors serving healthcare players. The Group's headquarters are based in Leuven, Belgium. More information is available at www.oxurion.com.
Important information about forward-looking statements
Certain statements in this press release may be considered "forward-looking". Such forward-looking statements are based on current expectations, and, accordingly, entail and are influenced by various risks and uncertainties. The Company therefore cannot provide any assurance that such forward-looking statements will materialize and does not assume any obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or any other reason. Additional information concerning risks and uncertainties affecting the business and other factors that could cause actual results to differ materially from any forwardlooking statement is contained in the Company's Annual Report. This press release does not constitute an offer or invitation for the sale or purchase of securities or assets of Oxurion in any jurisdiction. No securities of Oxurion may be offered or sold within the United States without registration under the U.S. Securities Act of 1933, as amended, or in compliance with an exemption therefrom, and in accordance with any applicable U.S. state securities laws.
Additional Disclaimer
________
The planned investment in digital assets (such as Bitcoin and Ethereum) exposes the company to specific risks related to volatility, regulatory uncertainty, and cybersecurity. These factors may significantly affect the expected performance of the investments.
For further information please contact:
Oxurion NV Pascal Ghoson Chief Executive Officer [email protected]
- Article 14, first paragraph, of the Law of 2 May 2007 on disclosure of major holdings.
ANNEX 1
| FSMA MARKETS AUTHORITY |
FINANCIAL SERVICES AND | Transparency notification Form TR-1 BE PART I |
||||
|---|---|---|---|---|---|---|
| 1) Status of the notification | ||||||
| Final | ||||||
| 2) Issuer | ||||||
| Name OXURION | ||||||
| Identification number 0881-620-924 | ||||||
| 3) Reason for the notification | ||||||
| Acquisition or disposal of voting securities or voting rights | ||||||
| 4) Notification by | ||||||
| A person that notifies alone | ||||||
| 5) Persons subject to the notification requirement | ||||||
| Name | Address (for legal entities) | |||||
| Atlas Special Opportunities II LLC | 2500 Westchester Avenue, Suite 401, Purchase, NY 10577 | |||||
| 6) Persons that dispose of voting rights (only to be filled in if art. 7 of the Law applies) | ||||||
| Name | Address (for legal entities) | |||||
| D | Please continue entering the information in part II concerning the persons referred to in Sections 5 and 6 | Part II | ||||
| 7) Date on which the threshold is crossed | ||||||
| 28/08/2025 (DD/MMYYYY) | ||||||
| 8) Threshold that is crossed (in %) | ||||||
| 10 | ||||||
| If the holding has fallen below the lowest threshold, you have the option of not entering any numbers in Section 10 | ||||||
| 9) Denominator | ||||||
| 50,377,523 | ||||||
| Please enter the denominator before filling in the data | ||||||
| 10) Notified details | ||||||
| A) Voting rights | Previous notification | After the transaction | ||||
| # of voting rights | # of voting rights | % of voting rights |
| # of voting rights | # of voting rights | % of voting rights | |||
|---|---|---|---|---|---|
| Holders of voting rights | Linked to securities | Not linked to the securities |
Linked to securities | Not linked to th securities |
|
| as Special Opportunities II LLC | 6,677,305 | 4.003.999 | 7.95% | ||
| TOTAL | 4,003,999 | 0 | 7.95% | 0.00% |
| B) Equivalent financial instruments | After the transaction | ||||||
|---|---|---|---|---|---|---|---|
| Holders of equivalent financial instruments |
Type of financial instrument | Expiration date | Exercise period or date |
# of voting rights that may be acquired if the instrument is exercised |
% of voting rights | Settlement | |
| + | |||||||
| TOTAL | 0 | 0.00% | |||||
| The totals will be updated once you have clicked on 1 |
|||||||
| TOTAL (A & B) | # of voting rights % of voting rights |
11) Full chain of controlled undertakings through which the holding is effectively held, if applicable
CALCULATE
4,003,999
7.95%
12) In case of proxy voting for only one GM
13) Additional information
On 13 August 2026, with sellenent date on 15 August 2020, Mas Special Operiorities II LC sold 2,420, 122 share in Oxurion its sharelating esceased b 0,07,305 shares (=
13.246
| Done at New York | ||
|---|---|---|
| On | 29/08/2025 (DD/MMYYYYY) | |
| Name & capacity Patrick Vance, Proxyholder | -Signed by: Signature Lathick Janable -9A8C4789B05442E |
For security reasons, the unsigned form in xlsx format should